share_log

Jefferies Maintains Buy on 4D Molecular Therapeutics, Raises Price Target to $58

Moomoo 24/7 ·  Apr 1 10:49

Jefferies analyst Nalin Tejavibulya maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and raises the price target from $30 to $58.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment